Wockhardt Limited
NSE:WOCKPHARMA.NS
1,236.3 (INR) • At close November 8, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Wockhardt Limited |
Symbool | WOCKPHARMA.NS |
Munteenheid | INR |
Prijs | 1,236.3 |
Beurswaarde | 189,668,200,800 |
Dividendpercentage | 0% |
52-weken bereik | 237.1 - 1,334.65 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Habil Fakhruddin Khorakiwala |
Website | https://www.wockhardt.com |
An error occurred while fetching data.
Over Wockhardt Limited
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK 5222, WCK 4282, WCK 4873, WCK
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)